12:00 AM
 | 
Jun 23, 2014
 |  BC Week In Review  |  Company News  |  Management Tracks

Protalix BioTherapeutics Inc management update

Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX), Carmiel, Israel
Business: Endocrine/Metabolic,...

Read the full 30 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >